🇺🇸 Guaifenesin Syrup in United States
20 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 20
Most-reported reactions
- Cerebrovascular Accident — 3 reports (15%)
- Clostridial Infection — 2 reports (10%)
- Drug Dispensing Error — 2 reports (10%)
- Drug Interaction — 2 reports (10%)
- Dysphagia — 2 reports (10%)
- Medication Error — 2 reports (10%)
- Nausea — 2 reports (10%)
- Pharmaceutical Product Complaint — 2 reports (10%)
- Respiratory Failure — 2 reports (10%)
- Accidental Drug Intake By Child — 1 report (5%)
Other Respiratory approved in United States
Frequently asked questions
Is Guaifenesin Syrup approved in United States?
Guaifenesin Syrup does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Guaifenesin Syrup in United States?
Liaoning University of Traditional Chinese Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.